Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lourdes Garcia, Quintanilla"'
Autor:
Samantha J. Montague, Pushpa Patel, Eleyna M. Martin, Alexandre Slater, Lourdes Garcia Quintanilla, Gina Perrella, Caroline Kardeby, Magdolna Nagy, Diego Mezzano, Paula M. Mendes, Steve P. Watson
Publikováno v:
Platelets, Vol 32, Iss 8, Pp 1018-1030 (2021)
Charge interactions play a critical role in the activation of the innate immune system by damage- and pathogen-associated molecular pattern receptors. The ability of these receptors to recognize a wide spectrum of ligands through a common mechanism i
Externí odkaz:
https://doaj.org/article/d68fe07341ea448db1db66c9eedf4d5e
Autor:
Marie-Blanche Onselaer, Magdolna Nagy, Chiara Pallini, Jeremy A Pike, Gina Perrella, Lourdes Garcia Quintanilla, Johannes A Eble, Natalie S. Poulter, Johan W.M. Heemskerk, Steve P Watson
Publikováno v:
Platelets, Vol 31, Iss 2, Pp 187-197 (2020)
Losartan and honokiol are small molecules which have been described to inhibit aggregation of platelets by collagen. Losartan has been proposed to block clustering of GPVI but not to affect binding of collagen. Honokiol has been reported to bind dire
Externí odkaz:
https://doaj.org/article/2e71e59d119541d1ac9e18548a387795
Autor:
Phillip L.R. Nicolson, Sophie H. Nock, Joshua Hinds, Lourdes Garcia-Quintanilla, Christopher W. Smith, Joana Campos, Alexander Brill, Jeremy A. Pike, Abdullah O. Khan, Natalie S. Poulter, Diedre M. Kavanagh, Stephanie Watson, Callum N. Watson, Hayley Clifford, Aarnoud P. Huissoon, Alice Y. Pollitt, Johannes A. Eble, Guy Pratt, Steve P. Watson, Craig E. Hughes
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Inhibitors of the tyrosine kinase Btk have been proposed as novel antiplatelet agents. In this study we show that low concentrations of the Btk inhibitor ibrutinib block CLEC-2-mediated activation and tyrosine phosphorylation including Syk and PLCγ2
Externí odkaz:
https://doaj.org/article/488fe4d4fc05448a940504d50e98e98e
Autor:
Christopher W. Smith, Maan H. Harbi, Lourdes Garcia‐Quintanilla, Kieran Rookes, Helena Brown, Natalie S. Poulter, Steve P. Watson, Phillip L.R. Nicolson, Mark R. Thomas
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2939-2952
New antithrombotic therapies with less effect on bleeding are needed for coronary artery disease. The Btk inhibitor ibrutinib blocks atherosclerotic plaque-mediated thrombus formation. However, it is associated with increased bleeding, possibly due t
Autor:
Paula M. Mendes, Pushpa Patel, Magdolna Nagy, Samantha J. Montague, Eleyna M. Martin, Lourdes Garcia Quintanilla, Alexandre Slater, Caroline Kardeby, Steve P. Watson, Gina Perrella, Diego Mezzano
Publikováno v:
Platelets, 32(8), 1018-1030. Routledge/Taylor & Francis Group
Charge interactions play a critical role in the activation of the innate immune system by damage- and pathogen-associated molecular pattern receptors. The ability of these receptors to recognize a wide spectrum of ligands through a common mechanism i
Autor:
Neil V. Morgan, Lorena Azocar, Gina Perrella, Jeremy A. Pike, Magdolna Nagy, Elizabeth E. Gardiner, Amanda Dalby, Johan W. M. Heemskerk, Steve P. Watson, Juan Francisco Miquel, Lourdes Garcia Quintanilla, Diego Mezzano, M. Francisca Becerra
Publikováno v:
Blood Adv
Blood advances, 4(13), 2953-2961. The American Society of Hematology
Blood advances, 4(13), 2953-2961. The American Society of Hematology
The role of glycoprotein VI (GPVI) in platelets was investigated in 3 families bearing an insertion within the GP6 gene that introduces a premature stop codon prior to the transmembrane domain, leading to expression of a truncated protein in the cyto
Autor:
Natalie S. Poulter, Joshua Hinds, Alexander Brill, Abdullah O. Khan, Sophie H. Nock, Phillip L R Nicolson, Craig E. Hughes, Joana Campos, Alice Y. Pollitt, Johannes A. Eble, Diedre M Kavanagh, Steve P. Watson, Callum N. Watson, Aarnoud Huissoon, Guy Pratt, Lourdes Garcia-Quintanilla, Christopher W Smith, Hayley Clifford, Stephanie Watson, Jeremy A. Pike
Publikováno v:
Haematologica. 106:208-219
Inhibitors of the tyrosine kinase Btk have been proposed as novel antiplatelet agents. In this study we show that low concentrations of the Btk inhibitor ibrutinib block CLEC-2-mediated activation and tyrosine phosphorylation including Syk and PLCγ2
Autor:
Gina Perrella, Samantha J. Montague, Helena C. Brown, Lourdes Garcia Quintanilla, Alexandre Slater, David Stegner, Mark Thomas, Johan W. M. Heemskerk, Steve P. Watson
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 493
International Journal of Molecular Sciences, 23(1):493. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 23, Iss 493, p 493 (2022)
International Journal of Molecular Sciences, 23(1):493. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 23, Iss 493, p 493 (2022)
Understanding the pathways involved in the formation and stability of the core and shell regions of a platelet-rich arterial thrombus may result in new ways to treat arterial thrombosis. The distinguishing feature between these two regions is the abs
Autor:
Lourdes Garcia-Quintanilla, Phillip L R Nicolson, Katrien Devreese, Caroline Kardeby, Stephen P. Watson, Walid Chayoua, Joost C. M. Meijers, Philip G. de Groot, Bas de Laat
Publikováno v:
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Journal of Thrombosis and Haemostasis
Journal of thrombosis and haemostasis, 19(7), 1776-1782. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 19(7), 1776-1782. Wiley
Journal of Thrombosis and Haemostasis
Journal of thrombosis and haemostasis, 19(7), 1776-1782. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 19(7), 1776-1782. Wiley
Background Arterial and venous thrombosis are both common in antiphospholipid syndrome (APS). Recent studies have shown that anti-factor Xa (FXa) therapy in APS patients leads to a greater number of patients with arterial thrombosis than with warfari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a9ffd6caa5d2d633ee8d1167a36759
https://hdl.handle.net/1854/LU-8703948
https://hdl.handle.net/1854/LU-8703948
Autor:
Marie-Blanche, Onselaer, Magdolna, Nagy, Chiara, Pallini, Jeremy A, Pike, Gina, Perrella, Lourdes Garcia, Quintanilla, Johannes A, Eble, Natalie S, Poulter, Johan W M, Heemskerk, Steve P, Watson
Publikováno v:
Platelets
Losartan and honokiol are small molecules which have been described to inhibit aggregation of platelets by collagen. Losartan has been proposed to block clustering of GPVI but not to affect binding of collagen. Honokiol has been reported to bind dire